
NASDAQ:CASM
The current stock price of CASM is 2.45 null. Today CASM is up by 0.41%. In the past month the price increased by 1.24%. In the past year, price increased by 114.91%.
ChartMill assigns a technical rating of 9 / 10 to CASM. When comparing the yearly performance of all stocks, CASM is one of the better performing stocks in the market, outperforming 97.99% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to CASM. Both the profitability and the financial health of CASM get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months CASM reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -27.2% | ||
| ROA | -54.94% | ||
| ROE | 263.39% | ||
| Debt/Equity | -4.08 |
CAS Medical Systems, Inc. develops and manufactures high-quality blood pressure measurement devices, vital signs monitors, apnea monitors and neonatal supplies that are the first choice of health care professionals around the world. CAS has earned a reputation for providing innovative, reliable products and backing them up with expert technical support. It works closely with health care providers to significantly improve the quality of patient care.
Cas Medical Systems
44 East Industrial Road
Branford CT 06405
CEO: Thomas M. Patton
Phone: 203-488-6056
CAS Medical Systems, Inc. develops and manufactures high-quality blood pressure measurement devices, vital signs monitors, apnea monitors and neonatal supplies that are the first choice of health care professionals around the world. CAS has earned a reputation for providing innovative, reliable products and backing them up with expert technical support. It works closely with health care providers to significantly improve the quality of patient care.
The current stock price of CASM is 2.45 null. The price increased by 0.41% in the last trading session.
CASM does not pay a dividend.
CASM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.